Tumor Blood Vessels as Targets for Cancer Therapy – Presented by Kyoko Hida Cancer Stromal Targeting Therapy – Presented by Yasuhiro Matsumura Developments of antibody-drug conjugate against tissue factor - Presented by Ryo Tsumura
In this workshop, we will:
- Investigate the biological effects of anti-tissue factor ADC in stroma-rich mouse model
- Evaluate the relationship between binding kinetics and tumor penetration ability
- Demonstrate the efficacy of anti-tissue factor ADC in several tumor models
Trastuzumab Deruxtecan (T-DXd, DS-8201a): An Overview of Pharmacology, Clinical Pharmacology, and Clinical Activity – Presented by Ronald Fleming
- Overview of the pharmacology of T-DXd
- Clinical pharmacology of T-DXd in cancer patients
- Summary of clinical studies in cancer patients
Ryo Tsumura, Research Scientist,National Cancer Centre
Kyoko Hida, Professor, University of Hokkaido
Ronald Fleming, Executive Director, Oncology Clinical Development, Daiichi Sankyo
Yasuhiro Matsumura, Director,National Cancer Centre